Literature DB >> 7110374

Metabolism of endogenous and exogenous noradrenaline in the rabbit perfused heart.

H Majewski, L Hedler, A Steppeler, K Starke.   

Abstract

The outflow of noradrenaline, 3,4-dihydroxyphenylglycol (DOPEG) and 3,4-dihydroxymandelic acid (DOMA) from rabbit perfused hearts was studied by chromatography on alumina followed by high pressure liquid chromatography with electrochemical detection. In the absence of drugs and without nerve stimulation, the outflow of endogenous noradrenaline over a period of 108 min averaged 0.17 pmol X g-1 X min-1 and the outflow of DOPEG 2.1 pmol X g-1 X min-1. The outflow of DOMA was below the detection limit (less than 0.13 pmol X g-1 X min-1). The effect of perfusion with (-)-noradrenaline 0.1, or 10 mumol/l for 18 min was then investigated. As the concentration of nor-adrenaline increased so did the outflow of DOPEG. Moreover, DOMA was found in the venous effluent during and after perfusion with noradrenaline 1 or 10 mumol/l. The increase in the outflow of DOPEG and DOMA was almost abolished when cocaine 10 mumol/l was present during the perfusion with noradrenaline 1 mumol/l. The release of endogenous noradrenaline by sympathetic nerve stimulation or tyramine 10 mumol/l, but not the release evoked by nicotine 30 mumol/l, was accompanied by an increase in the outflow of DOPEG; an outflow of DOMA was not observed. It is concluded that, in the rabbit perfused heart, DOPEG is an important metabolite of endogenous noradrenaline. DOMA is at best a minor product, either when the neurones are at rest or when noradrenaline is released by sympathetic nerve stimulation, nicotine or tyramine. DOMA is formed in detectable amounts when the tissue is exposed to a high concentration of exogenous noradrenaline. Like DOPEG, it is formed intraneuronally. The results confirm and extend those obtained previously on guinea-pig incubated atria. They make it unlikely that, in these tissues at least, DOMA formation is one of the physiological pathways of noradrenaline catabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110374     DOI: 10.1007/bf00503924

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  [Noradrenalin loss from the isolated rabbit heart following sympathetic nerve irritation and its pharmacological alteration].

Authors:  S HUKOVIC; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1962

Review 3.  The rate constants for the efflux of metabolites of catecholamines and phenethylamines.

Authors:  U Trendelenburg; H Bönisch; K H Graefe; M Henseling
Journal:  Pharmacol Rev       Date:  1979-09       Impact factor: 25.468

4.  Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria.

Authors:  E Adler-Graschinsky; S Z Langer; M C Rubio
Journal:  J Pharmacol Exp Ther       Date:  1972-02       Impact factor: 4.030

5.  An analysis of the effects of amezinium on postganglionic sympathetic neurones.

Authors:  A Steppeler; R Pfändler; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

6.  Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.

Authors:  S M Muldoon; P M Vanhoutte; G M Tyce
Journal:  Am J Physiol       Date:  1978-03

7.  Mechanism of noradrenaline release from rabbit atria induced by nicotinic agonists.

Authors:  C Sarantos-Laska; H Majewski; M W McCulloch; M J Rand
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-10

8.  An analysis of action of nicotinic agents on adrenergic nerve terminals in rat isolated vas deferens.

Authors:  S Jayasundar; M M Vohra
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-04

9.  Metabolism of endogenous and exogenous noradrenaline in guinea-pig atria.

Authors:  K Starke; L Hedler; A Steppeler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

10.  The disposition of 3H-(--)noradrenaline in the perfused cat and rabbit heart.

Authors:  K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

View more
  7 in total

1.  The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.

Authors:  E Schömig; C L Schönfeld; T Halbrügge; K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.

Authors:  T Halbrügge; B Friedgen; J Ludwig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

3.  Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.

Authors:  M Haass; M Hock; G Richardt; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

4.  The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart.

Authors:  M Grohmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

5.  The K+-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study.

Authors:  E Badoer; H Würth; D Türck; F Qadri; K Itoi; P Dominiak; T Unger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

6.  Tissue accumulation and release of newly synthesized 3H-dopamine and 3H-noradrenaline in canine saphenous veins incubated with 3H-(--)-tyrosine.

Authors:  P J Boels; T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

7.  The determination of presynaptic pA2 values of yohimbine and phentolamine on the perfused rat heart under conditions of negligible autoinhibition.

Authors:  H Fuder; E Muscholl; R Spemann
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.